Sympathetic activation in congestive heart failure

Reproducibility of neuroadrenergic markers

Guido Grassi, Gianbattista Bolla, Fosca Quarti-Trevano, Francesca Arenare, Gianmaria Brambilla, Giuseppe Mancia

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective: To assess the reproducibility of the two markers of adrenergic drive, venous plasma norepinephrine (NE) and efferent postganglionic muscle sympathetic nerve activity (MSNA), in reflecting the sympathetic activation characterizing congestive heart failure (CHF). Methods and measurements: In 19 CHF male normotensive patients (mean age: 53.0 ± 2.1 years, NYHA classes II and III, left ventricular ejection fraction 35.9 ± 2.9%), blood pressure (BP, Finapres), heart rate (EKG), plasma NE (HPLC assay) and MSNA (microneurography, peroneal nerve) were measured in two experimental sessions separated by a week interval. At each session, three NE samples were obtained and NE reproducibility between sessions was assessed by considering single NE samples or averaging 2-3 samples. Results: While MSNA values showed a highly significant correlation between sessions (r = 0.85, P <0.001), NE values based on a single blood sample evaluation did not correlate with each other (r = 0.41, P = NS). NE correlation coefficients improved and achieved statistical significance when average data from 2 and 3 blood samples were examined (r = 0.54 and r = 0.57, P <0.02 for both). Conclusions: In CHF, MSNA displays a better reproducibility pattern than plasma NE. The reproducibility of the NE approach, however, can be improved by performing the assay on multiple blood samples.

Original languageEnglish
Pages (from-to)1186-1191
Number of pages6
JournalEuropean Journal of Heart Failure
Volume10
Issue number12
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Norepinephrine
Heart Failure
Muscles
Peroneal Nerve
Stroke Volume
Adrenergic Agents
Myocardium
Electrocardiography
Heart Rate
High Pressure Liquid Chromatography
Blood Pressure

Keywords

  • Heart failure
  • Muscle sympathetic nerve activity
  • Muscle sympathetic nerve traffic
  • Plasma norepinephrine
  • Sympathetic activity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sympathetic activation in congestive heart failure : Reproducibility of neuroadrenergic markers. / Grassi, Guido; Bolla, Gianbattista; Quarti-Trevano, Fosca; Arenare, Francesca; Brambilla, Gianmaria; Mancia, Giuseppe.

In: European Journal of Heart Failure, Vol. 10, No. 12, 12.2008, p. 1186-1191.

Research output: Contribution to journalArticle

Grassi, Guido ; Bolla, Gianbattista ; Quarti-Trevano, Fosca ; Arenare, Francesca ; Brambilla, Gianmaria ; Mancia, Giuseppe. / Sympathetic activation in congestive heart failure : Reproducibility of neuroadrenergic markers. In: European Journal of Heart Failure. 2008 ; Vol. 10, No. 12. pp. 1186-1191.
@article{4ea39e0983ab40ddacd8782ed81590e7,
title = "Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers",
abstract = "Objective: To assess the reproducibility of the two markers of adrenergic drive, venous plasma norepinephrine (NE) and efferent postganglionic muscle sympathetic nerve activity (MSNA), in reflecting the sympathetic activation characterizing congestive heart failure (CHF). Methods and measurements: In 19 CHF male normotensive patients (mean age: 53.0 ± 2.1 years, NYHA classes II and III, left ventricular ejection fraction 35.9 ± 2.9{\%}), blood pressure (BP, Finapres), heart rate (EKG), plasma NE (HPLC assay) and MSNA (microneurography, peroneal nerve) were measured in two experimental sessions separated by a week interval. At each session, three NE samples were obtained and NE reproducibility between sessions was assessed by considering single NE samples or averaging 2-3 samples. Results: While MSNA values showed a highly significant correlation between sessions (r = 0.85, P <0.001), NE values based on a single blood sample evaluation did not correlate with each other (r = 0.41, P = NS). NE correlation coefficients improved and achieved statistical significance when average data from 2 and 3 blood samples were examined (r = 0.54 and r = 0.57, P <0.02 for both). Conclusions: In CHF, MSNA displays a better reproducibility pattern than plasma NE. The reproducibility of the NE approach, however, can be improved by performing the assay on multiple blood samples.",
keywords = "Heart failure, Muscle sympathetic nerve activity, Muscle sympathetic nerve traffic, Plasma norepinephrine, Sympathetic activity",
author = "Guido Grassi and Gianbattista Bolla and Fosca Quarti-Trevano and Francesca Arenare and Gianmaria Brambilla and Giuseppe Mancia",
year = "2008",
month = "12",
doi = "10.1016/j.ejheart.2008.09.013",
language = "English",
volume = "10",
pages = "1186--1191",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "John Wiley & Sons, Ltd",
number = "12",

}

TY - JOUR

T1 - Sympathetic activation in congestive heart failure

T2 - Reproducibility of neuroadrenergic markers

AU - Grassi, Guido

AU - Bolla, Gianbattista

AU - Quarti-Trevano, Fosca

AU - Arenare, Francesca

AU - Brambilla, Gianmaria

AU - Mancia, Giuseppe

PY - 2008/12

Y1 - 2008/12

N2 - Objective: To assess the reproducibility of the two markers of adrenergic drive, venous plasma norepinephrine (NE) and efferent postganglionic muscle sympathetic nerve activity (MSNA), in reflecting the sympathetic activation characterizing congestive heart failure (CHF). Methods and measurements: In 19 CHF male normotensive patients (mean age: 53.0 ± 2.1 years, NYHA classes II and III, left ventricular ejection fraction 35.9 ± 2.9%), blood pressure (BP, Finapres), heart rate (EKG), plasma NE (HPLC assay) and MSNA (microneurography, peroneal nerve) were measured in two experimental sessions separated by a week interval. At each session, three NE samples were obtained and NE reproducibility between sessions was assessed by considering single NE samples or averaging 2-3 samples. Results: While MSNA values showed a highly significant correlation between sessions (r = 0.85, P <0.001), NE values based on a single blood sample evaluation did not correlate with each other (r = 0.41, P = NS). NE correlation coefficients improved and achieved statistical significance when average data from 2 and 3 blood samples were examined (r = 0.54 and r = 0.57, P <0.02 for both). Conclusions: In CHF, MSNA displays a better reproducibility pattern than plasma NE. The reproducibility of the NE approach, however, can be improved by performing the assay on multiple blood samples.

AB - Objective: To assess the reproducibility of the two markers of adrenergic drive, venous plasma norepinephrine (NE) and efferent postganglionic muscle sympathetic nerve activity (MSNA), in reflecting the sympathetic activation characterizing congestive heart failure (CHF). Methods and measurements: In 19 CHF male normotensive patients (mean age: 53.0 ± 2.1 years, NYHA classes II and III, left ventricular ejection fraction 35.9 ± 2.9%), blood pressure (BP, Finapres), heart rate (EKG), plasma NE (HPLC assay) and MSNA (microneurography, peroneal nerve) were measured in two experimental sessions separated by a week interval. At each session, three NE samples were obtained and NE reproducibility between sessions was assessed by considering single NE samples or averaging 2-3 samples. Results: While MSNA values showed a highly significant correlation between sessions (r = 0.85, P <0.001), NE values based on a single blood sample evaluation did not correlate with each other (r = 0.41, P = NS). NE correlation coefficients improved and achieved statistical significance when average data from 2 and 3 blood samples were examined (r = 0.54 and r = 0.57, P <0.02 for both). Conclusions: In CHF, MSNA displays a better reproducibility pattern than plasma NE. The reproducibility of the NE approach, however, can be improved by performing the assay on multiple blood samples.

KW - Heart failure

KW - Muscle sympathetic nerve activity

KW - Muscle sympathetic nerve traffic

KW - Plasma norepinephrine

KW - Sympathetic activity

UR - http://www.scopus.com/inward/record.url?scp=56749169194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749169194&partnerID=8YFLogxK

U2 - 10.1016/j.ejheart.2008.09.013

DO - 10.1016/j.ejheart.2008.09.013

M3 - Article

VL - 10

SP - 1186

EP - 1191

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 12

ER -